149
Participants
Start Date
October 10, 2011
Primary Completion Date
September 30, 2019
Study Completion Date
September 30, 2019
TNF inhibitors
"TNF inhibitors are an FDA approved class of medications indicated for the treatment of RA when initial treatment (usually with methotrexate) has failed to achieve remission of RA disease activity. TNF inhibitors are part of the standard of care management of RA.~The possible TNF inhibitors are: Remicade, Humira, Enbrel, Cimzia, Simponi."
DMARDs
Standard of care treatment for RA, such as Methotrexate or other disease-modifying antirheumatic drugs.
Columbia University Medical Center, New York
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
Columbia University
OTHER